3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
64
Head and Neck Neoplasms
63
Squamous Cell Carcinoma of Head and Neck
60
Carcinoma, Non-Small-Cell Lung
34
Rectal Neoplasms
23
Colonic Neoplasms
23
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Squamous Cell
17
Pancreatic Neoplasms
13
Lung Neoplasms
13
Esophageal Neoplasms
11
Tongue Neoplasms
9
Stomach Neoplasms
9
Recurrence
9
Carcinoma
8
Neoplasms, Squamous Cell
6
Mouth Neoplasms
6
Laryngeal Neoplasms
6
Breast Neoplasms
6
Adenocarcinoma Of Esophagus
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Squamous Cell Carcinoma
5
Adenocarcinoma of Lung
5
Sarcoma
4
Salivary Gland Neoplasms
4
Oropharyngeal Neoplasms
4
Laryngeal Diseases
4
Precancerous Conditions
3
Hypopharyngeal Neoplasms
3
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
Cetuximab
×
Clear all
No trials found.